The 3 analysts offering 12-month price forecasts for Twist Bioscience Corp have a median target of 70.00, with a high estimate of 80.00 and a low estimate of 65.00. The median estimate represents a +5.66% increase from the last price of 66.25.
The current consensus among 4 polled investment analysts is to Buy stock in Twist Bioscience Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.69
Reporting Date Dec 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.